Abelacimab. Anti-factor XI/XIa monoclonal antibody, Treatment of atrial fibrillation, Treatment of thrombotic disorders
Authors:
- J. HardyJHJ. Hardy
- A. SperryASA. Sperry
- H. HartmannHHH. Hartmann
- R. GoldfadenRGR. Goldfaden
- M. AshchiMAM. Ashchi
- R. KimRKR. Kim
- J. HustonJHJ. Huston
- S. NimanSNS. Niman
- R. ChoksiRCR. Choksi
- 1 January 2021
- journal article
- Published by Portico in Drugs of the Future
- Vol. 46 (12) , 955